Unknown

Dataset Information

0

Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans.


ABSTRACT: Removal of the fucose residue from the N-glycans of the Fc portion of immunoglobulin G (IgG) results in a dramatic enhancement of antibody-dependent cellular cytotoxicity (ADCC) through improved affinity for Fcγ receptor IIIa (FcγRIIIa). Here, we present the 2.2-Å structure of the complex formed between nonfucosylated IgG1-Fc and a soluble form of FcγRIIIa (sFcγRIIIa) with two N-glycosylation sites. The crystal structure shows that one of the two N-glycans of sFcγRIIIa mediates the interaction with nonfucosylated Fc, thereby stabilizing the complex. However, fucosylation of the Fc N-glycans inhibits this interaction, because of steric hindrance, and furthermore, negatively affects the dynamics of the receptor binding site. Our results offer a structural basis for improvement in ADCC of therapeutic antibodies by defucosylation.

SUBMITTER: Mizushima T 

PROVIDER: S-EPMC3258418 | BioStudies | 2011-01-01

SECONDARY ACCESSION(S): 1E4K

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5653758 | BioStudies
2015-01-01 | S-EPMC4596520 | BioStudies
2018-01-01 | S-EPMC6255169 | BioStudies
2018-01-01 | S-EPMC6238083 | BioStudies
2013-01-01 | S-EPMC3788586 | BioStudies
2018-01-01 | S-EPMC6142058 | BioStudies
2012-01-01 | S-EPMC3364259 | BioStudies
2012-01-01 | S-EPMC3427744 | BioStudies
2018-01-01 | S-EPMC5825196 | BioStudies
2017-01-01 | S-EPMC5693878 | BioStudies